An observational study in Preeclampsia and Acute Kidney Injury, sponsored by Cairo University. Completed at 1 site in Egypt. Open to female participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-05-29.
Sponsored by Cairo University · Observational
To evaluate diagnostic accuracy of venous excess ultrasound score to predict acute kidney injury
Preeclampsia is a common health problem during pregnancy. such condition may result in serious consequences including acute kidney injury. researchers of this study aim to evaluate the ability of venous excess ultrasound score at hospital admission to predict acute kidney injury in preeclampsia with severe features
882 studies on the registry are indexed under Pre-Eclampsia; 237 are open to participants now.
This study's enrollment of 70 is below the median of 163 across 380 observational studies indexed under Pre-Eclampsia.
Browse Pre-Eclampsia studies →Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
preeclampsia with severe features
Exclusion Criteria:
Features of severity will be defined according to American college of obstetric and gynacology guidelines
Device: Venous excess ultrasound score (VEXUS)
Doppler examination of inferior vena cave, portal vein, hepatic vein, and intrarenal vein will be conducted by an experienced operator
The accuracy of VEXUS score at admission to predict acute kidney injury
Time frame: within 48 hours of admission
need for renal replacement therapy
Time frame: at 28 days of admission
Cumulative fluid balance
Time frame: within 48 hours of admission
In hospital mortality
Time frame: At 28 days of admission
Plan to share: No — Individual participant data (IPD) may not be shared due to privacy regulations, ethical considerations
This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cairo University